10 Reasons OrganiGram Is the Top Canadian Marijuana Stock to Own
Ready or not, earnings season has kicked off for the cannabis industry, with OrganiGram Holdings (NASDAQ: OGI) among the first to dish on its latest results.
In the company's fiscal first quarter, ended Nov. 30, OrganiGram delivered year-over-year net sales growth of 102% to 25.2 million Canadian dollars (about $19.3 million U.S.), which handily surpassed the CA$21 million in sales Wall Street had been looking for. The company's net loss of CA$0.9 million wound up reversing a big year-ago profit (which was largely aided by fair-value adjustments on biological assets), but that didn't stop OrganiGram's stock from skyrocketing 45% on Wednesday, Jan. 15.
While big gains in pot stocks have been fleeting of late, there's real reason to believe considerably better days lie ahead of OrganiGram. In fact, here are 10 reasons I believe OrganiGram is the best Canadian pot stock money can buy right now.
Source Fool.com
